SUPPORTING
INDEPENDENT RHEUMATOLOGY
ABOUT UNITED RHEUMATOLOGY
United Rheumatology is the pre-eminent rheumatology care management organization empowering rheumatologists to advance the standard of care while leading in the development of value-based precision medicine.
FEATURED RESOURCE
Group Purchasing
UR-GPO has contracted with pharmaceutical manufacturers to provide highly-competitive prices for pharmaceuticals, biologics and biosimilars.
FEATURED RESOURCE
Group Purchasing
UR-GPO has contracted with pharmaceutical manufacturers to provide highly-competitive prices for pharmaceuticals, biologics and biosimilars.
Unity is strength. I cannot imagine going alone in my journey as a solo private Rheumatologist. Wonderful things can be achieved with teamwork and collaboration. Success and growth are never by chance or when standing alone. They are the result of working United together!
LATEST NEWS
United Rheumatology executives Douglas Tardio, CEO and Jim Albano, executive vice president of Payer Strategy and Operations, were recently profiled by Healio Rheumatology. The article, which appears on Healio’s website, offers an in-depth look at United Rheumatology and our efforts to support and sustain independent rheumatologists. Tardio and Albano also share how UR is actively … Read moreHealio Rheumatology features United Rheumatology execs Tardio and Albano
Read More
LATEST NEWS
United Rheumatology executives Douglas Tardio, CEO and Jim Albano, executive vice president of Payer Strategy and Operations, were recently profiled by Healio Rheumatology. The article, which appears on Healio’s website, offers an in-depth look at United Rheumatology and our efforts to support and sustain independent rheumatologists. Tardio and Albano also share how UR is actively … Read moreHealio Rheumatology features United Rheumatology execs Tardio and Albano
Read MoreNot a Member Yet?
United Rheumatology is the pre-eminent rheumatology care management organization empowering rheumatologists to advance the standard of care while leading in the development of value-based precision medicine.